# RO-013 — Release Decision

**Programme:** RO-013 — Wave 13 LIVE Release Operations  
**Volume:** CS1-015 · Campaign Omicron · `cs1015-1.0.0`  
**Date:** 2026-08-03  
**Authority:** EP-001 Publication APPROVED (HR-013) · EF-001 · CE-001 coverage law · FP-01  

---

## Decision

```text
RO-013 Wave 13 LIVE release: LIVE-COMPLETE — ACCEPTED WITH RESIDUAL
Deployment: PASS
Educational package delivery (CO-D1…CO-R1): PASS (package path)
Natural Continuity Front chain (CX-R1 → CO-D1…CO-R1): PASS (true Omicron substance after Xi)
Progressive confidence (PB-015): AUTHORISED — NOT EXECUTED
Ops label desync / Finish-Home tomorrow chrome: RESIDUAL RO13-R1…R3 — tracked
Student LIVE credit for Omicron packages: AUTHORISED (package path)
Coverage register: 63 / 72 Learning Objectives (87.5%) — HELD (5.1 already Published via CS1-003)
Student Reliance: advanced through Topic 5.1
Wave 14: NOT STARTED
PB-015: AUTHORISED only — not started
```

**Coverage honesty note:** Topic 5.1 was already Approver-credited via Trust Front CS1-003. Wave 13 Continuity Front join does **not** increase Published Coverage. This decision **holds** Certified Educational Coverage at **63 / 72 (87.5%)** and advances **Student Reliance** through Topic **5.1** only after LIVE verification PASS. No commercial readiness, product completion, until-examination trust, or 100% CS1 claim.

---

## Exit criteria scorecard

| Criterion | Result |
|-----------|--------|
| Deployment succeeds | **Met** — tip `8432f6a8ddd06a07c20aab146ecceca7578ec116` live · deploy `dep-d9o9rdj7uimc738srkgg` |
| LIVE verification confirms approved educational experience | **Met for package path** — Guided Reading, CMP, activities, reflection, revision progression, no fallback on true Omicron path (`RO013_LIVE_VERIFICATION_REPORT.md`) |
| Progressive confidence | **Not run** — authorised as PB-015 only |
| No educational regressions introduced | **Met** for inventory + prior Continuity Front / Trust Front cold entries; residuals RO13-R1…R3 tracked (do not fail package-path LIVE-complete) |
| Publication status updated | **Met** — dashboard + coverage map + decision log |
| Published Coverage unchanged | **Met** — remains **63 / 72 (87.5%)** |
| Student Reliance advances through Topic 5.1 | **Met** after LIVE verification PASS |

**Campaign Omicron is LIVE-complete (package path).** PB-015 may begin under a separate authorised programme; this decision does **not** execute PB-015 or start Wave 14.

---

## What students receive

A diligent Internal Alpha student completing Continuity Front Xi / CX-R1 then receives the **approved CS1-015 Omicron packages** for LOs **5.1.1–5.1.9** plus **CO-R1** Revision — jointly activated, not as Isolated Golden Days. Trust Front cold entry at syllabus topic **5.1** remains **CD-D16** (independent Delta inventory).

---

## Governance updates required (executed with this decision)

1. `EP001_PUBLICATION_DECISION_LOG.md` — deployment commit, LIVE verify, checklist Done.  
2. `EP001_PUBLICATION_DASHBOARD.md` — Wave 13 LIVE Verified; PB-015 gated only by separate start authorisation.  
3. `EP001_COVERAGE_MAP.md` / `EP013_COVERAGE_UPDATE.md` — Approver credit **held** 63/72; Student Reliance advanced through Topic **5.1**.  
4. Student Reliance Coverage advanced through Topic **5.1** (no Approver double-count).

---

## Explicit non-claims

- PB-015 **not executed** by this decision (only authorised).  
- Wave 14 **not started**.  
- Until-exam educational trust **not** claimed from Wave 13 alone.  
- Published Coverage **not** increased (5.1 already counted via CS1-003).  
- **100% CS1 Approver coverage not claimed** (Wave 0 Alpha/Beta honesty gap remains).  
- Wave 0 Alpha/Beta Publication Approver honesty gap **not waived**.  
- Trust Front 5.1 **not** absorbed into Continuity Front credit.  
- Finish/Home tomorrow chrome **not** certified as matching package text on every Omicron day.  
- RO13-R1 Home / label desync **not** cleared.

---

## Residual register (ops follow-up — not Wave 14 content)

| ID | Residual | Owner class | Blocks LIVE-complete? | Blocks PB-015 start? |
|----|----------|-------------|------------------------|----------------------|
| RO13-R1 | Ops label desync during Continuity Front multi-day walks | PI / selection presentation | **No** | **No** |
| RO13-R2 | Revision-day checklist Q6 Learning-oriented audit on CO-R1 | Presentation / audit rubric | **No** | **No** |
| RO13-R3 | Tomorrow chrome residual on some Omicron days (incl. CO-R1) | PI / chrome | **No** | **No** |

---

## References

- `RO013_DEPLOYMENT_REPORT.md`  
- `RO013_LIVE_VERIFICATION_REPORT.md`  
- Evidence: `knowledge/evidence/releases/RO013/`  
- Commit: `8432f6a8ddd06a07c20aab146ecceca7578ec116`  
- Deploy: `dep-d9o9rdj7uimc738srkgg`  
- Inventory assert: `job-d9o9t1e7bikc73daa7r0`  

---

## Completion report sections

### Summary

RO-013 jointly activated Campaign Omicron on LIVE, verified educational fidelity on the Continuity Front package path (CX-R1 → CO-D1…CO-R1), and held Published Coverage at **63 / 72 (87.5%)** while advancing Student Reliance through Topic **5.1**. Exit criteria for LIVE-complete are met with tracked residuals. PB-015 remains not started.

### Files Created

- `RO013_DEPLOYMENT_REPORT.md`
- `RO013_LIVE_VERIFICATION_REPORT.md`
- `RO013_RELEASE_DECISION.md`
- `knowledge/evidence/releases/RO013/**`

### Files Modified

- Live package copies + campaign status + selection day-order / CX-R1 handoff (activation commit `8432f6a…`)
- `EP001_PUBLICATION_DECISION_LOG.md`
- `EP001_PUBLICATION_DASHBOARD.md`
- `EP001_COVERAGE_MAP.md`
- `EP013_COVERAGE_UPDATE.md`
- Related educational_packages / PB-002 tests (activation)

### Tests Executed

```text
pytest tests/application/educational_packages/ \
       tests/domain/session_experience/test_pb002_reflection_packages.py \
       tests/domain/session_experience/test_terminology.py -q
→ 196 passed
```

LIVE inventory assert · LIVE verification (package path rescored).

### Migration Impact

None.

### Architecture Compliance

EA-006 live loader + PB-002 selection day-order / Xi–Omicron–Delta coexistence preference only. Educational package bodies / Educational Framework / Runtime educational behaviour / recommendation logic unmodified beyond ops continuity wiring class already used in RO-001…RO-012.

### Technical Debt

RO13-R1 label desync and CO-R1 tomorrow chrome / Q6 residual remain open PI follow-ups outside Wave 14 content authoring.

### Known Limitations

Ops calendar backdating for multi-day verify; progressive confidence deferred to PB-015; Trust Front cold entry at 5.1 remains Delta; Approver coverage remains 63/72 (not 100%).

### Student Impact Assessment

- **Student problem:** Continuity Front stopped at 4.2 / CX-R1 before Wave 13 LIVE.  
- **Student benefit:** Diligent students can study approved Omicron days with CMP partnership on LIVE after Xi.  
- **Learning benefit:** Bayesian CF-join (5.1.1–5.1.9) + revision sequence is jointly live.  
- **Success metrics:** Deploy PASS · LIVE verify PASS WITH RESIDUAL · 0 fallback on true Omicron path · coverage **63 / 72 held** · reliance through Topic **5.1**.  
- **Risks:** Over-claiming until-exam trust or 100% Approver coverage; label desync RO13-R1; chrome residual; Approver double-count temptation.  
- **Assumptions:** Continuity Front progression through CX-R1; CMP remains external authority.

### Estimated KSI contribution

ΔKSI = 0 (ops release + validation evidence; no new educational product behaviour beyond inventory activation).

### Evidence collected

`knowledge/evidence/releases/RO013/` · deploy `dep-d9o9rdj7uimc738srkgg` · assert job `job-d9o9t1e7bikc73daa7r0`.

### Lessons learned for student value

Joint activation of a Continuity Front join onto already-Published Trust Front geography works when FP-01 is held, CX-R1 → CO-D1 selection is explicit, and Omicron/Delta coexistence is resolved without absorbing Trust Front credit. Ops label desync can mislabel expected-day detectors without corrupting session substance — keep those residuals separate from package-path trust. Progressive confidence must stay scoped to LIVE-certified inventory under PB-015. Holding Approver coverage at 63/72 after Omicron LIVE is itself a student-trust behaviour.

### Explainability Review

N/A — no intelligence change.

### Recommendation Quality Review

N/A — no ranking change.

### Version 1 readiness residual

Until-exam / Gate G1 not cleared. Wave 0 Approver gap open. RO13-R1 open (PI). PB-015 not executed. No 100% Approver-credit claim.

### CRI domains / ΔCRI

ΔCRI = 0 (ops validation; board not updated on provisional evidence alone).

---

Signed: Release Ops · RO-013 · 2026-08-03  
**Wave 13 LIVE status:** LIVE-complete (package path) · Residuals RO13-R1 / RO13-R2 / RO13-R3 open · **PB-015 authorised · not started** · **Wave 14 not started**
